Danaher Management

Management Kriterienprüfungen 3/4

Danaher CEO ist Rainer Blair , ernannt in Sep 2020, hat eine Amtszeit von 4.17 Jahren. Die jährliche Gesamtvergütung beträgt $20.90M , bestehend aus 6.2% Gehalt und 93.8% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.014% der Aktien des Unternehmens, im Wert von $22.63M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 5.8 Jahre bzw. 14.5 Jahre.

Wichtige Informationen

Rainer Blair

Geschäftsführender

US$20.9m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts6.2%
Amtszeit als Geschäftsführer4.2yrs
Eigentum des Geschäftsführers0.01%
Durchschnittliche Amtszeit des Managements5.8yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder14.5yrs

Jüngste Management Updates

Recent updates

Understanding Danaher's Cautiousness

Oct 25

Is There Now An Opportunity In Danaher Corporation (NYSE:DHR)?

Sep 28
Is There Now An Opportunity In Danaher Corporation (NYSE:DHR)?

Danaher Q3 Preview: Market Share Gains In Molecular Testing

Sep 25

Is Danaher Corporation (NYSE:DHR) Trading At A 32% Discount?

Sep 12
Is Danaher Corporation (NYSE:DHR) Trading At A 32% Discount?

Here's Why Danaher (NYSE:DHR) Can Manage Its Debt Responsibly

Aug 28
Here's Why Danaher (NYSE:DHR) Can Manage Its Debt Responsibly

Danaher: Lofty Price, Bright Future

Aug 22

Danaher Corporation's (NYSE:DHR) Price In Tune With Earnings

Aug 13
Danaher Corporation's (NYSE:DHR) Price In Tune With Earnings

Danaher: Valuation Now Too High Even Compared To Own High Standards

Jul 16

What Is Danaher Corporation's (NYSE:DHR) Share Price Doing?

Jun 23
What Is Danaher Corporation's (NYSE:DHR) Share Price Doing?

Mar Vista - Danaher: Headwinds Are Primarily Cyclical, Growth To Regain Momentum

Jun 20

Is Danaher Corporation (NYSE:DHR) Worth US$263 Based On Its Intrinsic Value?

Jun 05
Is Danaher Corporation (NYSE:DHR) Worth US$263 Based On Its Intrinsic Value?

Is Danaher (NYSE:DHR) A Risky Investment?

May 21
Is Danaher (NYSE:DHR) A Risky Investment?

It's Unlikely That Danaher Corporation's (NYSE:DHR) CEO Will See A Huge Pay Rise This Year

May 01
It's Unlikely That Danaher Corporation's (NYSE:DHR) CEO Will See A Huge Pay Rise This Year

Value Vs. Growth? Danaher Says Why Not Both?

Apr 25

Danaher: All In On Life Sciences, And Market Update

Mar 27

Is Now An Opportune Moment To Examine Danaher Corporation (NYSE:DHR)?

Mar 11
Is Now An Opportune Moment To Examine Danaher Corporation (NYSE:DHR)?

Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings

Feb 10
Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings

Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term

Jan 30

Is Danaher (NYSE:DHR) Using Too Much Debt?

Jan 12
Is Danaher (NYSE:DHR) Using Too Much Debt?

My Top 2024 Stock Pick: Danaher

Dec 27

Danaher: Poised For Long-Term Growth Despite Near-Term Hurdles

Nov 26

RGA Investment Advisors - Danaher:  Purity In The Crown Jewel Of Bioprocessing

Nov 19

Why Danaher Is One Of My Favorite Long-Term Investments

Oct 26

Danaher: Short-Term Headwinds, But Long-Term Tailwinds

Oct 17

Should Danaher Investors Sell New Veralto Shares?

Oct 02

Danaher Corporation's (NYSE:DHR) Intrinsic Value Is Potentially 18% Below Its Share Price

Sep 30
Danaher Corporation's (NYSE:DHR) Intrinsic Value Is Potentially 18% Below Its Share Price

Danaher: A Lost Year

Aug 30

Third Point - Danaher: Don't Be Surprised If Growth Rate Moves To Low Teens

Aug 02

Danaher: A Compounding Icon At A Fair Price

Jul 25

These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well

Jul 13
These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well

Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Jun 28
Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Danaher: Seizing The Buying Opportunity In A Temporary Bioprocessing Slump

Jun 22

At US$238, Is It Time To Put Danaher Corporation (NYSE:DHR) On Your Watch List?

Jun 15
At US$238, Is It Time To Put Danaher Corporation (NYSE:DHR) On Your Watch List?

Danaher: A Great Chance To Buy This Long-Term Compounder

May 23

With EPS Growth And More, Danaher (NYSE:DHR) Makes An Interesting Case

Apr 26
With EPS Growth And More, Danaher (NYSE:DHR) Makes An Interesting Case

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Rainer Blair im Vergleich zu den Einnahmen von Danaher verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 27 2024n/an/a

US$4b

Jun 28 2024n/an/a

US$4b

Mar 29 2024n/an/a

US$4b

Dec 31 2023US$21mUS$1m

US$4b

Sep 29 2023n/an/a

US$4b

Jun 30 2023n/an/a

US$5b

Mar 31 2023n/an/a

US$6b

Dec 31 2022US$20mUS$1m

US$6b

Sep 30 2022n/an/a

US$7b

Jul 01 2022n/an/a

US$6b

Apr 01 2022n/an/a

US$6b

Dec 31 2021US$17mUS$1m

US$5b

Oct 01 2021n/an/a

US$6b

Jul 02 2021n/an/a

US$5b

Apr 02 2021n/an/a

US$5b

Dec 31 2020US$10mUS$949k

US$4b

Oct 02 2020n/an/a

US$3b

Jul 03 2020n/an/a

US$3b

Apr 03 2020n/an/a

US$3b

Dec 31 2019US$7mUS$840k

US$2b

Sep 27 2019n/an/a

US$2b

Jun 28 2019n/an/a

US$2b

Mar 29 2019n/an/a

US$2b

Dec 31 2018US$5mUS$700k

US$2b

Sep 28 2018n/an/a

US$3b

Jun 29 2018n/an/a

US$3b

Mar 30 2018n/an/a

US$3b

Dec 31 2017US$4mUS$625k

US$2b

Vergütung im Vergleich zum Markt: RainerDie Gesamtvergütung ($USD20.90M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD12.73M).

Entschädigung vs. Einkommen: RainerDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.


Geschäftsführer

Rainer Blair (60 yo)

4.2yrs

Amtszeit

US$20,903,282

Vergütung

Mr. Rainer M. Blair serves as an Independent Non-Executive Director at Nestlé S.A. since April 20, 2023. He serves as President, Chief Executive Officer and Director at Danaher Corporation since September...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Steven Rales
Co-Founder & Chairman41.8yrskeine Daten6.02%
$ 10.0b
Rainer Blair
President4.2yrsUS$20.90m0.014%
$ 22.6m
Mitchell Rales
Co-Founder & Director41.8yrskeine Daten4.86%
$ 8.1b
Matthew McGrew
CFO & Executive VP5.8yrsUS$7.50m0.0053%
$ 8.8m
Jose-Carlos Gutierrez-Ramos
Senior VP & Chief Science Officer3.9yrsUS$7.20m0.00037%
$ 616.9k
Georgeann Couchara
Senior Vice President of Human Resources2.6yrsUS$5.25m0.00015%
$ 250.1k
Christopher Bouda
VP & Chief Accounting Officer2.8yrskeine Daten0.00081%
$ 1.4m
John Bedford
Vice President of Investor Relationsno datakeine Datenkeine Daten
Brian Ellis
Senior VP8.8yrsUS$3.56m0.0028%
$ 4.7m
Daniel Raskas
Senior Vice President of Corporate Development14.8yrskeine Daten0.0033%
$ 5.5m
William King
Senior Vice President of Strategic Development10.5yrskeine Daten0.0067%
$ 11.1m
Christopher Riley
Executive VP of Biotechnology Group & CEO of Cytivaless than a yearkeine Daten0.0020%
$ 3.4m

5.8yrs

Durchschnittliche Betriebszugehörigkeit

57yo

Durchschnittliches Alter

Erfahrenes Management: DHRDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (5.8 ).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Steven Rales
Co-Founder & Chairman41.8yrskeine Daten6.02%
$ 10.0b
Rainer Blair
President4.2yrsUS$20.90m0.014%
$ 22.6m
Mitchell Rales
Co-Founder & Director41.8yrskeine Daten4.86%
$ 8.1b
Alan Spoon
Independent Director25.8yrsUS$338.13k0.011%
$ 18.8m
John Schwieters
Independent Director21.3yrsUS$351.13k0.0054%
$ 9.0m
Elias Zerhouni
Independent Director15.8yrsUS$338.13k0.0024%
$ 3.9m
Raymond Stevens
Independent Director7.8yrsUS$318.13k0%
$ 0
Angela Caliendo
Member of Scientific Advisory Board3.6yrskeine Datenkeine Daten
Linda Filler
Lead Independent Director18.9yrsUS$382.13k0.0057%
$ 9.5m
Teri List-Stoll
Independent Director13.2yrsUS$318.13k0%
$ 0
Jessica Mega
Independent Director5yrsUS$318.13k0%
$ 0
Pardis Sabeti
Director5yrsUS$318.13k0%
$ 0

14.5yrs

Durchschnittliche Betriebszugehörigkeit

64yo

Durchschnittliches Alter

Erfahrener Vorstand: DHRDie Vorstandsmitglieder sind sehr erfahren ( 14.5 ).